Saxenda Dose Ladder Cheat Sheet: the Three-Day Trap

5 min read · doses off DailyMed · last verified October 2026

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

Saxenda is liraglutide at 3.0 mg, injected under the skin every day, approved for weight management back in 2014. It reaches its full dose in five weeks, far quicker than the weekly drugs. Each daily dose adds less accumulated exposure, so the gut catches up faster.

Daily dosing shapes almost everything else about this drug, for better and for worse.

The ladder

The ladder
WeekDaily doseWhat it is
10.6 mgA run-up. Below the level that does anything for weight; it is there for your stomach.
21.2 mgA treatment dose for diabetes under the Victoza name.
31.8 mgVictoza's ceiling. Appetite usually shifts noticeably around here.
42.4 mgOne below maintenance. Stay longer if your gut is objecting.
5 onward3.0 mgFull maintenance, and the dose the SCALE trials ran on.

Patients aged 12 and over follow the same steps, but the climb may be stretched to eight weeks if tolerance is poor, and dropping back a rung is explicitly permitted.

The three-day rule

None of the weekly drugs has a rule like this one.

  • Miss one day? Take the next scheduled dose as normal. Do not take extra to compensate and do not raise the dose to catch up.
  • Missed three days or more in a row? The label sends you back to 0.6 mg and up the entire ladder again.

The reason is the same short half-life that makes daily injection necessary: roughly 13 hours, against about seven days for semaglutide. Once the drug is out of you, so is your tolerance for it, and walking straight back in at 3.0 mg means walking straight back into the nausea. A long weekend of forgotten pens costs you a month.

Practical points

  • Daily, not weekly. The single biggest difference from Wegovy, Zepbound and Mounjaro. Any hour of the day, food irrelevant.
  • Belly, thigh or upper arm, moved every day, so you rotate seven times as often as you would on a weekly drug.
  • A week per step, and slowing down is allowed. Speeding up is not.
  • Storage: fridge until first use, then 30 days at room temperature or refrigerated, and then it goes regardless.
  • Never alongside another GLP-1, including Victoza, which is the same molecule under a different name.
  • On insulin or a sulfonylurea? Those doses usually need to come down before this one goes up.

Reasons to stop and call

  • Severe abdominal pain that persists, especially through to the back. The label says discontinue if pancreatitis is suspected.
  • Right-sided pain under the ribs, fever, yellowing, pale stools. Gallstones and gallbladder inflammation both showed up more on Saxenda than placebo in the SCALE program.
  • A day without keeping fluids down, dizziness on standing, dark or scanty urine. Kidney injury follows dehydration.
  • A neck lump, hoarseness, difficulty swallowing. The boxed warning covers thyroid C-cell tumors; medullary thyroid carcinoma in your history or family's, or MEN 2, rules the drug out.
  • Shaking, sweating, confusion where insulin or a sulfonylurea is also involved.
  • Hives, swelling of the face or throat, trouble breathing. Stop and get emergency care.

Whether to be on it at all

Semaglutide and Saxenda have been compared directly, in a randomized trial published in JAMA in 2022, and it was not close: weekly semaglutide's weight loss was more than twice that of daily liraglutide over 68 weeks (15.8% against 6.4%). More people stopped liraglutide early, too: 27.6% against 13.5% on semaglutide.

There are still reasonable grounds to be here:

  • You are established on it, tolerating it, and it is working.
  • The patient is 12 to 17, where Saxenda has carried a pediatric indication since 2020.
  • Your insurance covers liraglutide and not semaglutide. Given the price gap, that is a real argument.
  • You specifically want a drug that leaves your system in hours rather than a week, should something go wrong.

That last point is easy to overlook. A short half-life is a nuisance when you forget a dose and an advantage when you need the drug gone.

What this does not cover

This page covers Saxenda only: liraglutide at 3.0 mg for weight. It does not cover Victoza, the same molecule capped at 1.8 mg for diabetes on a different schedule. Nor does it cover pancreatitis workup, pediatric pharmacokinetics, pregnancy (the label says to stop Saxenda once a pregnancy is recognized), fasting before surgery, or use after bariatric surgery.

Where to go next

References

  1. 1.U.S. National Library of Medicine — DailyMed. SAXENDA (liraglutide) injection 3.0 mg — Structured Product Label. DailyMed (FDA-approved labeling, SetID 3946d389-0926-4f77-a708-0acb8153b143). 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
  2. 2.Rubino DM, Greenway FL, Khalid U, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (STEP 8). JAMA. 2022. PMID: 35015037.

Frequently Asked Questions

One missed day is not a problem. Carry on with the next dose at its usual time, without doubling up or raising the dose to compensate. Three or more consecutive missed days are different: the label sends you back to 0.6 mg to climb the whole ladder again, because the tolerance your gut built up disappears with the drug.
One week per step, five steps, 0.6 mg to 3.0 mg. Holding a step longer is allowed if the nausea has not settled, but moving faster is not. Patients aged 12 and over may stretch the whole climb to eight weeks, and may drop back a rung if a step proves too much.
Its half-life is about 13 hours, against roughly seven days for semaglutide and five for tirzepatide. It does not stay in your body long enough to work on a weekly schedule. That same property is why missing three days in a row forces a full restart, and also why it clears quickly if you need it gone.
No, and the two were compared head to head. In a randomized trial published in JAMA in 2022, weekly semaglutide's weight loss was more than twice that of daily liraglutide over 68 weeks. Saxenda still has a place: an established patient doing well on it, a pediatric indication it has held since 2020, insurance that covers it and not semaglutide, or a preference for a drug that leaves the system in hours rather than a week.

Editorial reference content, not medical advice. Changing a dose, holding one, or stopping altogether is a decision for you and your prescriber together. As for the numbers: we checked every dose figure here against the FDA-approved Structured Product Label on DailyMed in October 2026.

Browse all cheat sheets, top-N research lists, or long-form research deep-dives.